Winning Sectors (S&P 500, Q1 returns as of March 31)

Energy dominated everything — the gap between best and worst sectors hit nearly 50 percentage points.

Rank	Sector	Q1 Return	Key Driver
1	Energy	+37.9%	Oil price surge from Iran war disruptions (Strait of Hormuz shipping issues)
2	Materials	+10.7%	Commodity strength tied to energy/inflation
3	Utilities	+8.3%	Defensive play in risk-off environment
4	Consumer Staples	+6.1%	Defensive, inflation-resistant
5	Industrials	+4.6%	Value rotation + domestic focus

Losing Sectors (S&P 500, Q1 returns)

Growth and rate-sensitive sectors suffered the most.

Rank	Sector	Q1 Return	Key Driver
1	Financials	-9.4%	Private credit worries, AI exposure, higher-for-longer rates
2	Consumer Discretionary	-8.5%	Rotation out of growth + high valuations
3	Information Technology	-7.5%	“AI loser trade” — fears AI disrupts software/business models
4	Communication Services	-5.5%	Tech-adjacent weakness
5	Health Care	-4.9%	Mild laggard in rotation

Winning Sectors (S&P 500, Q1 returns as of March 31)

Energy dominated everything — the gap between best and worst sectors hit nearly 50 percentage points.

Rank	Sector	Q1 Return	Key Driver
1	Energy	+37.9%	Oil price surge from Iran war disruptions (Strait of Hormuz shipping issues)
2	Materials	+10.7%	Commodity strength tied to energy/inflation
3	Utilities	+8.3%	Defensive play in risk-off environment
4	Consumer Staples	+6.1%	Defensive, inflation-resistant
5	Industrials	+4.6%	Value rotation + domestic focus

Losing Sectors (S&P 500, Q1 returns)

Growth and rate-sensitive sectors suffered the most.

Rank	Sector	Q1 Return	Key Driver
1	Financials	-9.4%	Private credit worries, AI exposure, higher-for-longer rates
2	Consumer Discretionary	-8.5%	Rotation out of growth + high valuations
3	Information Technology	-7.5%	“AI loser trade” — fears AI disrupts software/business models
4	Communication Services	-5.5%	Tech-adjacent weakness
5	Health Care	-4.9%	Mild laggard in rotation

Top Small Cap Losers

1. NCT (Intercont Cayman Limited): -31% to -36.59% Trading around $1.75–$1.90. Heavy selling after a 25-for-1 reverse stock split that became effective around April 2. Reverse splits often trigger immediate pressure as they signal distress (e.g., to regain Nasdaq $1 bid price compliance) and can attract short sellers. Recent announcements around European expansion provided only temporary relief before fading.
2. NVNI (Nvni Group Limited): -33.12% Around $1.05. Ongoing pressure from repeated Nasdaq non-compliance notices (minimum market value of listed securities $35M and bid price issues). The company has a history of restatements, accounting errors, and reverse split considerations. Persistent dilution fears and weak financial health (negative equity/ongoing losses) weigh on sentiment.
3. RDGT (Ridgetech Inc.): -23% to -27% Extremely low-priced (~$0.018–$0.02, micro-cap). Announcement of a massive 1-for-150 reverse split effective April 7 is the main trigger — these large consolidations often lead to heavy selling. Very low market cap (~$300K–$500K) and high volume reflect speculative retail rotation out.
4. GV (Visionary Holdings Inc.): -21% to -23% Around $0.34. Profit-taking after a recent surge on a $20M anti-aging/China partnership deal. The rally faded quickly amid broader concerns over weak fundamentals (FY2025 revenue down 46%, large net losses, asset impairments, liquidity issues). Classic "buy the rumor, sell the news" in a micro-cap.

Overall Context Today:
Small cap losers are dominated by reverse split fallout and profit-taking in highly speculative/micro names. The Russell 2000 is mixed overall, but these low-priced stocks amplify moves on thin volume. No major broad sector selloff — it's mostly company-specific. Energy and some defensives are soft on geopolitics, but small caps are more news-driven.

WHAT ARE YOUR THOUGHTS ?

Small Cap Winners (Biggest % Movers)

These are often lower-priced/volatile names reacting to fresh news:

• PFSA (Profusa): +151–156% Massive surge after announcing a $30M Letter of Intent to acquire PanOmics (precision diagnostics platform). This expands into the multi-billion-dollar diagnostics market, adds shareholder equity, and strengthens ties with Mayo Clinic/pancreatic cancer focus. Classic small-cap M&A catalyst with huge volume spike.
• FCUV (Focus Universal): +132–146% Strong move on momentum from recent IoT/5G tech updates and AI/SEC financial reporting software launches (plus earlier sales division news). Low-float small cap prone to explosive retail-driven rallies.
• AIXI (Xiao-I): +99–101% Legal victory: China’s Supreme Court upheld its core AI patent, rejecting Apple’s invalidation attempt. Removes major overhang and validates its AI IP in a high-stakes space.
• SLNO (Soleno Therapeutics): +32% Acquisition news: Neurocrine Biosciences agreed to buy it for ~$2.5–2.9B ($53/share cash, big premium). Biotech buyout in rare disease/endocrinology space

Biggest Winners by Market Cap Category – YTD as of April 3, 2026

2026 has been a broadening market year so far. Large-cap tech (especially the “Magnificent 7”) has lagged or turned negative, while smaller companies have rotated into leadership.

Index-level YTD performance (price returns, approx. through late March/early April):

• Small-caps (Russell 2000 / S&P SmallCap 600) → +0.7% to +4.8% (value subset even stronger)
• Mid-caps (Russell Midcap / S&P MidCap 400) → +1.2% to +3.6%
• Large-caps (S&P 500 / Russell 1000) → -4.2% to -5.1% (mega-caps down ~7–8%)

Small-caps have the biggest overall YTD gains (both on an index basis and in raw percentage moves for individual stocks). Micro-caps have been even stronger in many cases. This is the clearest “small-cap outperformance” stretch in years.

Why Small-Caps Are Winning the Most

• Rotation away from mega-cap tech — High valuations + AI hype fatigue hit the Mag 7 hard; money flowed into cheaper, domestically focused small/mid-caps.
• Energy/oil tailwind — Geopolitical tension (Iran conflict) pushed oil >$110, boosting small-cap explorers and refiners.
• Biotech & speculative catalysts — Binary clinical or partnership news creates 200–400%+ moves in low-float names.
• Valuation & earnings edge — Small-caps trade at big discounts and have higher projected 2026 earnings growth vs. large-caps.
• Broader market theme — Value > growth, small > large, international > U.S. in early 2026.

Top Individual Winners by Category (YTD % Gains)

Small-Cap Winners (typically <$2–10B market cap; many micro-caps dominate raw %

Rank	Ticker & Company	YTD Gain (approx.)	Market Cap	Sector / Catalyst
1	LIFE (Ethos Technologies)	+267%	~$340M	Financials/tech momentum
2	SATL (Satellogic)	+205%	~$756M	Industrials/space/satellite demand
3	KOS (Kosmos Energy)	+196–227%	~$1.6B	Energy/oil price surge (biggest small-cap story overall)
4	ANL (Adlai Nortye)	~+459–476%	~$300M	Biotech/clinical momentum
5	CYCN (Cyclerion Therapeutics)	~+384%	~$23M	Biotech catalyst

Mid-Cap Winners (roughly $2–20B market cap)

Mid-cap gains are strong but generally less extreme than small-cap % movers.

Rank	Ticker & Company	YTD Gain (approx.)	Market Cap	Sector / Catalyst
1	TCGL (TechCreate Group)	+3,223%	~$2.6B	IT (extreme outlier)
2	ERAS (Erasca)	+379%	~$5.5B	Biotech/healthcare
3	IBRX (ImmunityBio)	+269%	~$7.7B	Biotech
4	ALMS (various smid names)	+157%+	Mid-range	AI/thermal management

Large-Cap Winners (>$20B market cap; S&P 500 leaders)

Rank	Ticker & Company	YTD Gain (approx.)	Market Cap	Sector / Catalyst
1	SNDK (Sandisk Corp.)	+172–195%	~$103B	Tech/semiconductors (NAND/AI demand)
2	LITE (Lumentum Holdings)	+124%	~$58B	Tech/optics
3	VG (Venture Global)	+115%	~$36B	Energy
Others	CIEN, WDC, TPL, MRNA, GNRC	+60–90% range	Large	Tech/energy/healthcare

Top Small-Cap Winners YTD 2026 (Biggest % Gainers)

These are mostly micro/small-cap with low floats; many are not "value" stocks

Rank	Ticker & Company	Approx. YTD Gain	Market Cap (approx.)	Why It's Winning
1	LIFE (Ethos Technologies)	+267%	~$340M	Strong momentum in financials/tech; top-ranked small-cap performer on multiple screeners.
2	SATL (Satellogic)	+205%	~$756M	Industrials/space/tech catalyst; satellite imagery demand.
3	KOS (Kosmos Energy)	+196–227%	~$1.6–1.7B	Energy sector leader — oil price surge (> $110 WTI) from geopolitics boosted oil & gas explorers. Frequently #1 overall small-cap gainer.
4	ANL (Adlai Nortye)	+459–476%	~$300M	Biotech/pharma; clinical or partnership momentum.
5	CYCN (Cyclerion Therapeutics)	+384%+	~$23M (micro)	Biotech catalyst — one of the most extreme small-cap movers.
Others (extreme)	BNAI, SHAZ, BW (Babcock & Wilcox)	+1,300%+ / +148%+	Micro to small	Speculative/biotech or industrial turnaround plays.

Rank	Ticker & Company	% Gain (approx.)	Market Cap (approx.)	Primary Reason
1	GV (Visionary Holdings)	+110–116%	Very low (~$2–3M)	Extreme volatility in a low-float name; possible retail frenzy or short squeeze.
2	SKYQ (Sky Quarry)	+100–102%	Low	Oil price surge (> $110 WTI) boosting energy/refining-related plays; strategic value in Nevada refinery amid high Brent crude.
3	TMDE (TMD Energy)	+75–76%	~$40M	Energy sector momentum tied to geopolitical oil spike.
4	CYCN(Cyclerion Therapeutics)	+300%+ (multi-day)	Micro	Biotech catalyst/news (strongest reported mover).
Others	BRAI, SELX, COCP, SIDU	+40–50%+	Low	AI/partnership news or sector rotation.

Rank	Ticker & Company	% Decline (approx.)	Market Cap (approx.)	Primary Reason
1	LPCN (Lipocine Inc.)	-77% to -78%	~$15M	Phase 3 trial failure: Oral brexanolone (LPCN 1154) for postpartum depression did not meet the primary endpoint (no statistically significant HAM-D score improvement vs. placebo at hour 60). Classic biotech clinical miss triggered massive sell-off.
2	ELAB (PMGC Holdings Inc.)	-63%	~$3M	Sharp reversal after recent heavy gains (e.g., +113% on annual report filing and license deals days earlier). Extremely low-float micro-cap; likely profit-taking, lack of follow-through news, or dilution pressure in a volatile name.
3	INO (Inovio Pharmaceuticals)	-35% to -36%	~$78M–120M	Hit new 52-week lows amid high volume. No single major catalyst reported today, but ongoing biotech sector weakness, cash-burn concerns, and general selling in small-cap biopharma names.
4	IOBT (IO Biotech)	-32%	~$2M	Continuation of earlier pressure (company had explored strategic alternatives like merger/sale/liquidation in prior months). Very low market cap adds to extreme volatility.
5	MAXN(Maxeon Solar Technologies)	-27% to -28%	~$14M	Liquidity crisis: Recently sought Singapore judicial management for key units. Ongoing revenue declines, patent issues, and broader solar/renewable energy sector weakness amplified the drop.

Top Small-Cap Losers (Biggest % Decliners)

Small-cap losers today include some spillover from earnings misses/guidance and biotech "sell the news" reactions. Note that some previously mentioned large/mid-cap losers like RH (~$2B market cap, borderline small/mid) and ORIC (~$1–1.4B) also impact small-cap sentiment.

1. ORIC – ORIC Pharmaceuticals, Inc. (down significantly in recent sessions, ~10%+ intraday pressure at times)
   • Market Cap: ~$1.2–1.4B (small-cap biotech).
   • Why? "Sell the news" after announcing the recommended Phase 3 dose for rinzimetostat (in combination therapy) for a prostate cancer trial (Himalayas-1). While this advances the pipeline toward potential registrational data in 2026+, investors often react negatively to dosing/timeline details if they signal slower progress, higher costs, or dilution risks. Biotech stocks are notoriously volatile on trial updates.
2. RH – RH (Restoration Hardware) (~-19% to -21% at ~$109–113)
   • Market Cap: ~$2.1B (small/mid-cap luxury retailer).
   • Why? Weak Q4/FY2025 results and ongoing pressure from the high-end housing slowdown, tariffs, and discretionary spending caution. Luxury furnishings have been hit hard by macro uncertainty; the stock was already in a downtrend, and the earnings reaction amplified selling. High volume reflects institutional exits.

1. .Firefly Aerospace Inc. (FLY) — Down ~11.58% (to around $23.70 range in screened data; market cap ~$3.8B, borderline small/mid but frequently grouped in small-cap discussions due to volatility). Why in detail: This aerospace/rocket company (focused on small satellite launches with its Alpha rocket) has seen repeated pressure from earnings misses, operational setbacks (e.g., prior rocket test issues), and high cash burn in a capital-intensive industry. Recent moves often link to quarterly results anticipation, where lower-than-expected revenue or widened losses weigh on sentiment. Broader market sell-offs in tech/growth names and geopolitical factors (e.g., energy/oil volatility impacting sector flows) amplify swings. Firefly remains unprofitable with execution risks in launch cadence, making it sensitive to any delay or macro headwinds. Volume was elevated in downside sessions, suggesting profit-taking after prior pops on successful flights.

• Clear Secure, Inc. (YOU) — Down ~11.16% in a recent session (to ~$47.44; market cap in the $2B+ range but often screened with small/mid growth names). Why: Despite strong year-to-date gains driven by airport chaos (e.g., government/TSA-related delays boosting enrollment in its biometric fast-lane services), the stock pulled back on profit-taking and broader market weakness. Leadership changes (e.g., general counsel departure) added minor noise, though operational tailwinds from travel disruptions have supported longer-term adoption. It lagged the S&P 500 on down days, reflecting sensitivity as a growth-oriented name in consumer/tech services. High short-term momentum earlier in March led to natural consolidation.
• Vertical Aerospace Ltd. (EVTL) — Down ~13.81% in screened sessions (to ~$2.06; small-cap market cap ~$200M range). Why in detail: This eVTOL (electric vertical takeoff and landing aircraft) developer faces ongoing liquidity and "going concern" warnings, with high cash burn, delayed commercialization timelines, and dilution risks from funding needs. Recent earnings or updates highlighted operating losses (e.g., ~$127M for 2025) and challenges transitioning from development to production. The sector is high-risk/high-reward, with regulatory hurdles and competition weighing on investor confidence.